Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nothing yet for Nov. 28th...
https://www.uspto.gov/learning-and-resources/official-gazette/official-gazette-patents
Not a narrative. Fact: 211.01(b)(I). Patents will be issued on a Tuesday shortly after the patent number is assigned.
https://www.uspto.gov/learning-and-resources/official-gazette/official-gazette-patents#:~:text=The%20Official%20Gazette%20for%20Patents,each%20patent%20issued%20that%20week.
CEO thinks the current market price 0.001 is very good timing to buyback 210m shares from the $210K cash they received from a film licence fee.
$ABQQ *MUST READ* DD (Part 2)
— Stock Picks NYC (@StockPicksNYC) November 27, 2023
•Closer look at ABQQ reveals their focus on movies and video streaming services. ABQQ TV generates revenue, they have a subscription and advertising business similar to Netflix $NFLX and Disney $DIS
•AB Cinemas, physical movie theater like $AMC… https://t.co/ifo1kRzJ48 pic.twitter.com/fTu5M9yxMo
Bring on FOMOnday!
Meet the man who's going to make you a boatload of cash!
FOMO Monday coming.
Swift.
That close was a thing of beauty. Next week should be fun.🤩
Joseph Kurczodyna's video bio from 2013 regarding a private mortgage company he started in 2009. He's had quite the career, and this is clearly going to be his crowning achievement.
Patent application stickied above. They received the NOA (Notice of Allowance) on 10-19-23 which means once the fee is paid (and I'm assuming they paid it immediately), the patent will be issued within 4-6 weeks. Patent news comes on Tuesdays, so if they did indeed pay the fee immediately (and why wouldn't they?), the patent should be issued tomorrow or the following Tuesday. Hold tight!
The author of the new MicrocapDaily article (link below) completely missed that AB INTERNATIONAL GROUP enjoys nice revenues from its ownership of AB CINEMAS MT. KISCO in Mt. Kisco, NY. https://www.abcinemasny.com/
https://microcapdaily.com/ab-international-group-otc-abqq-beyond-the-numbers-strategic-evolution-in-the-entertainment-industry/
Should be stickied.
1 day? 4 1/2 days?
How many trading days before patent announcement? Not many more left! 😁
53,000 X followers
You stickied the public patent search link and maybe that was your intention, but I think you meant to sticky the actual patent application (link below).
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20220261893
2 more patent applications..
SYSTEM AND METHOD FOR FACILITATING A PUBLIC OFFERING ON AN IMMUTABLE BLOCKCHAIN PROVIDED TO ELIGIBLE QUALIFIED INVESTORS BASED UPON PRIORTY OF INTEREST
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20220261892
SYSTEM AND METHOD FOR PREPARING FOR A SEC FINANCIAL STATEMENT AUDIT BY RECORDING CORPORATE GOVERNANCE INFORMATION ON AN IMMUTABLE BLOCKCHAIN
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20220261925
Found the patent application...
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20220261893
So they got the NOA on 10-19-23. Assuming they paid the fee immediately, and why wouldn't they, the patent is issued 4-6 weeks from receiving payment. The 6-week mark is 11-30-23, so I would say the latest we hear news is Tuesday, 11-28-23. Could be as early as tomorrow (11-16-23 is the 4-week mark). Remember, patents are issued on Tuesdays.
https://www.accesswire.com/795852/blackstar-will-receive-a-patent-on-its-revolutionary-digital-trading-platform-a-blockchain-encrypted-infrastructure-designed-to-enable-digital-assets-that-are-securities-to-trade-on-a-blockchain
All patents are issued on Tuesdays.
If the examiner determines that your application meets the patent requirements, you or your legal representative will receive a Notice of Allowance. This means you are entitled to a patent. This will list the issue fee and may also include the publication fee. Expect your patent to grant about 4-6 weeks after payment of the issue fee. All patents are issued on Tuesdays.
https://www.accesswire.com/795852/blackstar-will-receive-a-patent-on-its-revolutionary-digital-trading-platform-a-blockchain-encrypted-infrastructure-designed-to-enable-digital-assets-that-are-securities-to-trade-on-a-blockchain
Bruce Colclasure, new board director of future spin-off BioAdaptives® LiveStock Impact™, a well-known and successful livestock nutritionist, breeder, competitor, winner, and owner of numerous champion horses commented “This marks the first of a full line of natural, effective and cost-friendly wellness supplements that will complement each livestock nutrition program. Our Equine Regen Plus® has performed with remarkable success. We have now expanded this to provide products that are able to nourish every cell in your livestock’s body with supplements from the earth that are minimally processed, mostly plant-based, and naturally packed with essential nutrients and powerful antioxidants that will help livestock look, feel, and perform at their best. We are excited to continue to offer parallel products to promote wellness and performance in companion pets and other shown animals.”
$38 billion spent directly on equine care goods and services
LIVESTOCK IMPACT™ EQUINE ALL-IN-ONE™
U.S. Equestrian Foundation and American Horse Counsel surveys show approximately 7 million horses and over 6 million owners, workers and other service providers in the US involved in recreation, racing, and showing. Equine business has a total annual GDP impact of over $100 billion and over $38 billion spent directly on goods and services relating to equine care. International markets, especially in the Middle East, exceed domestic figures by significant amounts. Our target market is well-defined and exceptionally resistant to economic downturns. True horse people take care of their animals regardless of what is going on elsewhere.
Just made a general observation.
Why would anyone trust the statements of an admitted flipper? Motives are obvious. Just saying.
Looks like the panic chasing has begun.
A number of us received the same email in July. It's legitimate. Hoping they respond to AJ.
Thank you for your recent inquiry into BioAdaptives (BDPT), Livestock Impact (an operating unit of the Company serving animal-based clients), and our current activities. We appreciate your interest and your input. Whether a shareholder, potential investor, or an interested outside party we welcome all requests for information concerning our company.
Due to our sizable and diverse shareholder base, and the legal requirement to keep everyone as equally informed as possible, we use a variety of methods designed to identify and share the latest most current Company information / data to as many people as possible. First, we rely upon the Forms reporting necessary to stay current with SEC requirements for all public companies. Our 10-Q & 10-K submittals offer timely quarterly updates (a new 10-Q for the second quarter will be filed within the next three weeks), and, in addition, 8-K reports are used to announce material events as they are concluded. Other SEC filings are prepared as situations and events demand. Also, we use periodic press releases to report key events via postings on a variety of media outlets. Finally, our primary website, info@bioadaptives.com, as well as product-specific sites, are kept current with news, products, and key company activities.
With the above tools we attempt to provide vehicles providing an opportunity for everyone to stay equally and fairly informed reqarding key events and decisions. Our goal is to keep the communications current and helpful.
Thanks again for your interest and inquiry. I hope this helps in understanding our process.
Bob Ellis, President & Director
BioAdaptives, Inc.
Las Vegas, Nevada USA
rwe@bioadaptives.com
Worth repeating: "The stock market is a device for transferring money from the impatient to the patient." -Warren Buffett
Can't take any credit. Just cut and paste. Mostly from Powerbattles. Hope it helps.🙂
Thanks, Crazy Horse. Added LiveStock Impact/Primicell info to my sticky.
PENDING A GLOBAL DRUG SPIN-OFF:))) Massive upside coming... (DD courtesy of Powerbattles)
$BDPT This company stands out as one of the most solid and fundamentally strong investments I've come across in my years of researching of companies on the OTC market. It's a true gem worth considering.
Spin-off news - 9-27-23
https://finance.yahoo.com/news/bioadaptives-inc-redefines-expanding-role-120000372.html
https://www.livestockimpact.com/
Primicell Study
“Stem cell research can revolutionize medicine, more than anything since antibiotics.” ~Ronald P. Reagan
https://www.livestockimpact.com/pages/primicell-study
Here are some of the BDPT August DD posts.
* August 14
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172586435
* August 13
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172586192
* August 9
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172550289
* August 8 (not DD, price at .0026)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172546513
DD part # 1 Good times ahead! SPIN-OFF
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172123754
It appears that the company is poised for the next phase of growth. The recent high-profile recruitments at BioAdaptives since April 2023 have been incredibly exciting for the company. These recruitments include top-notch professionals who are prepared to take us to the next level.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172664261
CEO Dr. Edward E. Jacobs
Patents by Inventor Edward E. Jacobs, Jr.
https://patents.justia.com/inventor/edward-e-jacobs-jr
https://podcasts.apple.com/be/podcast/natural-green-living/id1523571157?l=nl
CEO Dr. Edward E. Jacobs Graduated the best Ivy League school Leagues. Graduate of Harvard Medical school and Princeton University. IVY Legue School ranked
1 - HARVARD
2 - PRINCETON
https://prepexpert.com/ivy-league-school-rankings/#:~:text=Ivy%20League%20Schools%3A%20Ranked%201%201.%20Harvard%20Harvard,7%207.%20Dartmouth%20...%208%208.%20Cornell%20
Recent announcements of new board members, an upcoming spin-off, new products/patents/licensing agreements, and more.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172165338
Article by Boe Rhimes of Newsytrends
https://newsytrends.com/2023/09/05/bioadaptives-inc-otcmkts-bdpt-rising-as-management-taking-primicell-stem-cell-activator-to-the-next-level/
Again all, let's strive for civility. In these times it's difficult, I know.
Tothe, hope you're working with Shelly to get your DD on the sticky. Posted mine a short while ago (included your August cut and pasted DD).
PENDING A GLOBAL DRUG SPIN-OFF:))) Massive upside coming... (DD courtesy of Powerbattles)
$BDPT This company stands out as one of the most solid and fundamentally strong investments I've come across in my years of researching of companies on the OTC market. It's a true gem worth considering.
Spin-off news - 9-27-23
https://finance.yahoo.com/news/bioadaptives-inc-redefines-expanding-role-120000372.html
Here are some of the BDPT August DD posts.
* August 14
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172586435
* August 13
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172586192
* August 9
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172550289
* August 8 (not DD, price at .0026)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172546513
DD part # 1 Good times ahead! SPIN-OFF
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172123754
It appears that the company is poised for the next phase of growth. The recent high-profile recruitments at BioAdaptives since April 2023 have been incredibly exciting for the company. These recruitments include top-notch professionals who are prepared to take us to the next level.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172664261
CEO Dr. Edward E. Jacobs
Patents by Inventor Edward E. Jacobs, Jr.
https://patents.justia.com/inventor/edward-e-jacobs-jr
https://podcasts.apple.com/be/podcast/natural-green-living/id1523571157?l=nl
CEO Dr. Edward E. Jacobs Graduated the best Ivy League school Leagues. Graduate of Harvard Medical school and Princeton University. IVY Legue School ranked
1 - HARVARD
2 - PRINCETON
https://prepexpert.com/ivy-league-school-rankings/#:~:text=Ivy%20League%20Schools%3A%20Ranked%201%201.%20Harvard%20Harvard,7%207.%20Dartmouth%20...%208%208.%20Cornell%20
Recent announcements of new board members, an upcoming spin-off, new products/patents/licensing agreements, and more.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172165338
Article by Boe Rhimes of Newsytrends
https://newsytrends.com/2023/09/05/bioadaptives-inc-otcmkts-bdpt-rising-as-management-taking-primicell-stem-cell-activator-to-the-next-level/
I have been made a moderator today as well. Shelly has graciously allowed me to post a sticky. I have chosen one of Powerbattles' posts. If you think there are better options, I am open to suggestions. Let's make this board what it once was back in the summertime, or at the very least, strive for civility.
Link to 10-11-23 Form 1-A Offering Statement [Regulation A] below:
http://pdf.secdatabase.com/181/0001477932-23-007567.pdf
DR. TED - CEO - Board Chairman
Dr. Edward E. Jacobs, Jr. (Dr. Ted), a graduate of Princeton University and Harvard Medical school, is a biotechnology consultant with over 25 years of experience in biopharmaceutical and medical device development, as well as 35 years of teaching and direct patient care.
Dr. Ted has participated in drug development processes, from discovery through animal and human studies, including regulatory support for FDA, and international regulatory affairs, strategic planning,
and investor relations.
Dr. Ted has extensive clinical operations experience, having executed more than 15 human trials in the U.S., Europe, and South Africa. He has also served as a Medical Monitor and Liaison for clinical investigators involved with international trials, with responsibility for regulatory compliance.
In his research, Dr. Ted has made original observations in the field of artificial blood, tissue oxygenation therapy, and water modification. His current focus is on natural products for human and animal use, anti-aging strategies, and primitive cell biology. He is an author of more than 40 scientific publications, and is the holder of 4 patents.
Robert Ellis, President and Director, brings more than forty years of business management experience to the Company. He has worked extensively in senior positions across a variety of industry disciplines, including aerospace, electronics, communications, and international marketing. Mr. Ellis has been an executive officer in private and public companies, both major entities, start-ups, and emerging entities. He has an Accounting Degree from the University of Illinois, and is a CPA.
Charles Townsend, COO and Director, brings over 30 years of experience in operations and enterprise marketing to the BioAdaptives team. Mr. Townsend has a Bachelor of Arts degree in accounting from the University of Texas and an MBA from the University of North Texas.
Board director David Allen, PhD, is a visionary futurist and wellness pioneer. He is CEO of World Wellness and co-founder and President of the American Botanical Drug Association. He has developed a value web network of influential people in various nations during the course of his many life journeys in education, philosophy, science and business.
He teaches that the future of health and wellness, life extension and life enhancement will be based on the integration of principles of ancient and modern healing systems, whole food plant-based nutrition and the latest scientific advances in biotech, nanotechnology, neuro cognitive enhancement, stem cell research, quantum science and artificial intelligence.
https://www.botanicaldrug.org/
Within the past decade, LY Research, a company engaged in the development, manufacturing and marketing of botanical drug products and nutraceuticals in China, Europe, and the U.S, and its owner, Dr. Yaguang Liu have received 32 patents from the U. S. Patent and Trademark Office for safe natural botanicals, used for treatment of Alzheimer’s, Cardiovascular, Myopia and other conditions. New BioAdaptives board director, Dr. Liu was born and educated in the People’s Republic of China. He graduated from Fudan University, Shanghai and had been a visiting Professor at the Department of Medicine of the University of Chicago. He established the Molecular Medicine Institute in China and was a director of this institute. He has authored four books: (1) An Investigation of the Combined Theories of Chinese and Western Medicines from the Angle of Molecular Biology; (2) Molecular Biology in Heart Disease; (3) Principles of Theoretical Medicine; and (4) Natural Science and the Theory of Chinese Medicine.